Fox Run Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Fox Run Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,987	Closed	-$312K	–	426
2019 Q4	$312K	Buy	+2,987	New	+$335K	0.25%	182
2019 Q3	–	Sell	-1,617	Closed	-$279K	–	633
2019 Q2	$279K	Sell	1,617 -586	-27%	-$101K	0.19%	255
2019 Q1	$371K	Buy	+2,203	New	+$328K	0.21%	196
2018 Q3	–	Sell	-3,446	Closed	-$481K	–	905
2018 Q2	$481K	Buy	+3,446	New	+$489K	0.15%	264
2018 Q1	–	Sell	-3,256	Closed	-$430K	–	1008
2017 Q4	$430K	Sell	3,256 -1,644	-34%	-$193K	0.13%	334
2017 Q3	$497K	Buy	4,900 +100	+2%	+$10.7K	0.14%	300
2017 Q2	$481K	Buy	+4,800	New	+$517K	0.17%	231

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fox Run Management's GWPH Position: Q1 2020 in Review

Fox Run Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 2,987 shares — an estimated $312K sold.

Fox Run Management first reported a position in GWPH in Q2 2017 and held it in 7 quarters. The position peaked at $497K in Q3 2017. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Fox Run Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Fox Run Management sold 2,987 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $312K.
Fox Run Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2017 and held it in 7 quarters.
Fox Run Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $497K in Q3 2017.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Fox Run Management's 13F filing for Q1 2020, filed 8 May 2020.